• Users Online: 1111
  • Home
  • Print this page
  • Email this page

   Table of Contents      
Year : 1962  |  Volume : 10  |  Issue : 4  |  Page : 83-102

Sanguinarine & hypothalamic glaucoma

1 From the National Institute for Medical Research, Mill Hill, London, United Kingdom
2 The Sofa Hakim Medical Research Centre, 249 Dr. D. Naoroji Road, Bombay, India

Date of Web Publication17-Mar-2008

Correspondence Address:
Sohrab A.E Hakim
From the National Institute for Medical Research, Mill Hill, London
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

How to cite this article:
Hakim SA, Phil D. Sanguinarine & hypothalamic glaucoma. Indian J Ophthalmol 1962;10:83-102

How to cite this URL:
Hakim SA, Phil D. Sanguinarine & hypothalamic glaucoma. Indian J Ophthalmol [serial online] 1962 [cited 2022 Jul 6];10:83-102. Available from: https://www.ijo.in/text.asp?1962/10/4/83/39555

Table 2

Click here to view
Table 2

Click here to view
Table 1

Click here to view
Table 1

Click here to view

  A West Indies Poppy Comes To India Top

Here is a story, a true story which can rival any tale of fiction, one chapter of which began nearly four hundred years ago when Elizabeth the First was the Queen of England. In the city of London there lived a famous herbalist John Gerard, who grew beautiful flowers gathered from all parts of the world. In that epoch of adventure and discovery one of his friends brought for him a few black seeds from the West Indies, which must have looked very much like our Indian mustard seeds, and they blossomed in his Bloomsbury garden into a beautiful yellow poppy with silver-veined but prickly leaves. This American poppy, first described in Gerard's 'Herbal', was soon introduced to Oxford, Paris and other European gardens. Because of its orange latex, it was wrongly identified with 'argemone', a Mediterranean poppy with orange juice, reputed to cure "eye diseases" in ancient Greek classical medicine, and baptised Argemone mexicana Tournefort (1694), Linnaeus (1753), [Figure - 1], the suffixes in honour of the great taxonomists. This was a most un­fortunate mistake, for this American weed neither came from Mexico nor does it possess the reputed eye-curing virtues of the hitherto unknown 'argemone' herb. Probably because of tais mistaken is identifica­tion and spurious reputation, the plant was deliberately introduced by the Portuguese into Africa and Goa in Western India.

The weed spread like magic and soon covered vast areas of Africa, India, South-East Asia, China and Australia. It is one of the most prolific and common weeds in the eastern tropics and all of us here have seen entire fields covered by this yellow prickly poppy, growing from the winter to the rains. It is specially important to emphasise to an Indian audience that this American plant was unknown in India and deliberately introduced into this country only during the last two hundred years and that it cannot therefore, be equated with any plant of ancient Ayurveda. With its ill-fated destiny for mis­baptism, the new arrival, because it yielded a "golden milk", was falsely identified in India with 'Svarnakshiri', an obsolete Ayurve­dic healing herb. Ainslie, in his first (western) pharmacopoea of Indian drugs, as far back as 1813, recorded that our Vaidyas and Hakims freely prescribe the plant and seeds for diseases of the skin and eyes.

Argemone seeds are both ac­cidently and deliberately used to adulterate mustard seeds (Indraji, 1910) and their seed-oil to adulterate other edible seed-oils. The arge­mone stem is cooked and eaten as a salad in many parts of Bengal and Bihar.

Argemone seed-oil is used as a purgative in the Mauritius Islands, Abysinnia, South Africa and India and for colic, cholera and sedation in our country. The seeds are used as a narcotic and for diarrhoea and dysentry, the herb as a diaphoretic, expectorant, diuretic, and applica­tion for eczema and ophthalmia.

The herb and its seed-oil are pre­scribed in many modern Ayurvedic works (Jadavji, 1950) and are easily available to people in our villages. As the Honorary Secretary to the Bombay Government Committee on Research in Ayurveda, I interview­ed and corresponded with a large number of practising Vaidyas. It was alarming to find most of them wrongly insisting that Argemone mexicana L., is an indigenous Indian therapeutic herb, and some advocating its poisonous oil as a laxative.

  Epidemic-dropsy Glaucoma & World Glaucoma Top

Records are available from 1860 of epidemics of dropsy occurring in India and affecting large groups of persons. Between 1866 and 1954, thirty epidemics are officially re­corded. Glaucoma associated with Dropsy was recorded several times after 1909. In the 1935 epidemic, 7,000 people were affected, over 700 developed glaucoma and 1,500 died. Our Indian workers in Bengal first obtained the clue that oil presses had been used to extract argemone seed-oil and subsequent­ly for extraction of sesame or other cooking oils. Persons ingest­ing the contaminated cooking oils developed symptoms of the disease. These observations of Sarkar and Kamath in 1926 and 1928 completed a seventy-year epoch of search for the cause of the devastating epidemics of dropsy and blindness. S. N. Sarkar, my predecessor at Oxford, working under Sir Rudolph Peters, showed that argemone seed­oil contained two alkaloids, san­guinarine and dihydrosanguinarine, and tried to explain some of the clinical observations on the bioche­mical blockage of pyruvate met­abolism by sanguinarine. I took up pharmacological studies with san­guinarine from several different aspects and succeeded in produc­ing both dropsy and rise of eye tension in experimental animals. (Hakim, 1953, 1954, Duke-Elder, 1954).

At that stage it seemed obvious that the Indian epidemics of dropsy and glaucoma and records of argemone poisoning in animals were caused mainly by the toxic alkaloid sanguinarine present in argemone seed-oil. The next pro­blem was whether some of the glaucoma occurring in Europe and America could also result from in­gestion of some insidious toxins. To establish any such international hypothesis, dual evidence would be required that sanguinarine or similar toxins occur in these non­-tropical countries and that they can be available to man. This hypothesis, which seemed so fan­tastic in 1953, is now well within the range of probability, as I have been fortunate in finding multiple and rich sources of sanguinarine in most parts of the world, as well as several routes by which this blind­ing poison could reach man.

  Sanguinarine & Other Eye Tension Raising Alkaloids in Plants Top

Sanguinarine is a benzphenanthridine alkaloid belonging to the iso-quinoline group. Over 114 iso-quinoline alkaloids are known and some of them like morphine, codeine and papaverine are amongst the most active and useful of drugs. Iso-quinoline alkaloids are usually found in plants belonging to two large botanical families, the poppies and fumarias, but they also occur sporadically in twelve other plant families (Manske, 1954). Sanguinarine was hitherto regard­ed as a rare and obscure alkaloid first isolated 133 years ago from Sanguinaria canadensis L., the 'blood-root' used by the North American Indians to paint them­selves scarlet. During the last one and a half centuries, the "epoch of alkaloid detection", chemists found sanguinarine in only eight other poppy-fumaria plants. Working at the National Institute for Medical Research, London, under the guid­ance of Sir Robert Robinson and Dr. James Walker, we found that sanguinarine was present and abundant in most morphological parts of nearly fifty species of poppy-fumaria weeds we examined [Table - 1]. All that was required was a few milligrams of plant material ground in acetic acid, se­parated either by paper chromato­graphy or electrophoresis and com­pared with standard alkaloids. Sanguinarine, and at times ten other related alkaloids, were se­parated from a few drops of this simple extract and showed striking and beautiful fluorescent colours under filtered ultra-violet light. Sanguinarine was more or less in­variably present in the leaves and stems, often in the roots, capsules and seeds, and was the commonest fluorescent alkaloid seen in these species. It seems to have been missed for so many years because of its unusual solubility and absence of adequate .tests. The details of our methods of extrac­tion, detection, identification and results have been published else­where. (Hakim et al., 1961a).

An example of how sanguinarine had hitherto escaped chemical detec­tion is found in the 'opium' poppy Papaver somniferum L. No plant has been more thoroughly in­vestigated in the annals of chemistry, and yet sanguinarine was missed in this plant. We found it in its roots, stems and leaves. The young plants are used as edible herbs in the middle East and like the 'fumitory' herb, deliberate­ly fed to cattle.

You will realise a little later on the purpose of this elaboration into the phyto-chemistry of sanguinarine. At this stage, I am trying to bring out the widespread source of san­guinarine in plants, firstly because a few of these are directly ingested by man, and secondly, as I shall show later, a large number of such plants grow as prolific weeds in most parts of the world (Fedde, 1909; Hutchinson, 1921), are grazed upon by cattle, who absorb their toxic alkaloids, store them in their liver and secrete them in their milk.

Those of you who have seen the cornfields of Europe and North India will recollect the myriads of scarlet poppies (Papaver rhoeas L., P. hybridum L., and P. dubium L.) growing amongst the grain. Every­one of these poppies contain san­guinarine in either its roots, stems, leaves or seeds. The poppies are collected with the harvest and con­tribute their poisons both to the grain and to the dried fodder which is fed to cattle.

On this table is a vase filled with the Indian 'fumitory' (Fumaria in­dica Pugsley), an elegant weed I collected this morning from the fields of Amritsar. It grows throughout the Indo-Gangetic plain and on the hills of South India and is very similar to the soecies that grow abundantly throughout Persia, the Middle East, Europe and America. Shakespeare (1523) de­scribed the European species ([Figure - 2]-Fumaria officinalis L.) as grow­ing wild and prolific in the fields of France. The roots and seeds of both species are rich in san­guinarine. I wish to draw your special attention to this herb as it is likely to be responsible for a con­siderable number of cases of en­demic rather than epidemic glau­coma in our country, throughout the Middle East, and in other parts of the world.

The 'fumitory' herb has been widely used as a medicine, and must have contributed an insidious source of sanguinarine during its recorded history covering over 2,000 years! This herb was known as 'Kaonos' in ancient Greek classical medicine and prescribed by Dios­corides and Pliny. Under its Arabic na-ne of 'Shahtiraj', it was used by Ibn Seranion, Ibnu'l-Baytar, Ibn 'Awwam, 'Abd ar-Razzaq, Rabi Mai­monides and others and its use continued throughout the Middle East unto the present day. As 'Shahterah, it was well-known to the physicians of Persia, Ar-Razi, 'Ali ibnu'l 'Abbas al-Ma usi, Abu 'Ali Sina and Isma'il Jurjani and its use was introduced into the Mughal. school of Yunani medicine in lnaia through works like the Makhzan­el-Adwia. The herb is well known in North India as 'Sathra' (often confu­sed with 'Pitpapda'), and is com­monly used as a Yunani and even as an Ayurvedic decoction for fevers, skin and kidney diseases, blood-purification etc. Our hostess, on watching me collect the herb this morning, strongly recommended it for treatment of "women's dis­eases" (? !). So deep-rooted is this ancient tradition that not only Shakespeare but practically every ancient and modern herbal through­out Europe, extolls the virtues of the European 'fumitory' and of several species of poppies. Even the Na­tional Formulary (1960), the Dis­pensatory of the United States of America (1960) and the British Pharmaceutical Codex (1949) spon­sor the use of Sanguinaria canadensis L., the 'blood-root' over­flowing with the scarlet alkaloid sanguinarine !

Several orange-red stems and roots were prescribed as direct applications for the eyes in ancient empirical systems of medicine. These are usually from poppy-fumaria or closely related genera. The oldest extant of Ayurvedic texts - the Bower Manuscript - re­commends the application of 'rasot', an extract of berberis. Dioscorides used 'argemone', probably a thalictrum. The famous 'mamiran', from coptis, corydalis or thalictrum, was prescribed by Al-Ghafiqi in Spain, and is extensively used, even at present, in Afghanistan and North India.

The first link connecting san­guinarine to its possible aetiology in world glaucoma, was the chemi­cal investigation I have described earlier. It became evident that sanguinarine was not a rare and obscure alkaloid, but a glaucoma­genetic toxin definitely found and abundant in most parts of at least sixty-two poppy-fumaria species [Table - 1]. Since the alkaloid was present in so many species distributed in 14 representative genera, it seems very likely that it will be found in most or all of the nearly seven hundred species of this vast plant family. If you visualise rice fields in spring, teem­ing with thousands of yellow argemone, or vegetable gardens scattered with the purple fumaria in early winter, or fields of wheat amongst which thousands of scarlet poppies fill an autumn landscape, you will realise how densely just three out of these hundreds of species can grow and, therefore, what an abundant source of san­guinarine is available in the plant kingdom.

The next significant discovery was that the eye tension-raising action of sanguinarine on experimental animals is not the unique property of this alkaloid, but that several similar alkaloids also produce acute rise of eye tension in experimental animals. My early Oxford experi­ments had shown that, besides sanguinarine, chelerythrine and a ­number of crude poppy extracts when injected subconjunctivally or intra-ocularly in rabbits and mon­keys, raised their eye tension. Lieb and Scherf from Prof. Thiel's group at Frankfurt, later showed that seven out of fourteen iso-quinoline alkaloids, injected intravenously into anaesthetized rabbits, produced acute rise of eye tension. When these alkaloids were later available to me through the kindness of Dr. Manske, I produced acute rise of eve tension by their sub-con­junctival injection.

Whilst working at the National Institute for Medical Research, I found a new and very interesting technique of raising eye tension by injecting minute doses of sanguin­arine into the brain of conscious cats. The very first injection of sanguinarine given by this method in 1957, raised eye tension it was also significant that several other iso-quinoline alkaloids, besides sanguinarine, when injected into the brain also produced acute rise of eye tension [Table - 2]. As these other alkaloids, sent by Dr. Manske, belong to twelve plant families, besides poppy-fumarias, it is inter­esting to speculate if iso-quinoline alkaloids found in species of spinach, for example, or others found in the custard-apple or the Indian bael-fruit, or even in oranges and limes, may have some subtle insidious action in the aetiology of widespread glaucoma.

  Transmission of Sanguinar­ine to Man Through Milk Top

It is of little practical importance to know that sanguinarine and other eye tension raising alkaloids are abundantly and widely dis­tributed in plants growing in all parts of the world. The whole crux and importance of the experiments is the demonstration that these toxins reach and affect man. From the beginning, I realised that con­tamination of cooking oils by argemone oil could not explain the large number of endemic cases of human glaucoma in India or glau­coma in other parts of the world where the argemone plant does not flourish. Inquiries among my ophthalmological colleagues sug­gested that the Joins as a people have a higher incidence of this disease. If glaucoma in vegetarian Jains is related to some plant toxin, the most obvious link is the milk they consume in abundance. This trend of thought fostered a series of experiments in my laboratory at Bombay during 1954-56, in which I fed goats with argemone leaves, took their milk and fed it to rhesus monkeys and succeeded in produc­ing prolonged raised eye tension which was maintained at a raised level for many weeks. During these experiments it was found that the tension in the monkeys could be more rapidly raised and more adequately maintained when the goat's milk containing the trans­mitted poison was separated, the lactalbumin portion being rejected, whilst the casein-fat portion was incorporated into a low-cystein, low-vitamin A synthetic cake, which was fed to the monkeys.

The argemone herb contains seven other alkaloids besides sanguin­arine and in spite of its thorns and bitter taste, is know to poison cattle and horses in Australia and the U.S.A., and goats and donkeys in Africa, where it has been declared a "noxious weed". Arrgemone mexicana L. var : ochroleuca Lindl., is a favourite food of the ostrich and is browsed upon in times of drought by goats and sheep in Africa. Another thorny species, Papaver aculeatum Thunb., also contains sanguinarine and is con­sidered as a good fodder in Australia. Poisoning to poultry and live-stock by argemone seeds has been recorded in Africa, the Mauritius Islands and Australia.

  Protective Action of Cysteine Top

The goats fed on argemone leaves showed a small rise of eye tension. It is known that goats fed on D. D. T. transmit this poison in their milk without adverse effects to themselves, or to their young, although the poisoned milk is lethal when fed to rats. The removal of lactalbumin from the milk of goats fed on argemone leaves was based on my Oxford experiments which had shown that the toxic effects of sanguinarine were neutralised by nor-adrenaline, adrenaline, cysteine or B. A. L. The lactalbumin fraction in milk, which contains the bulk of the cysteine, would partially protect against the toxic actions of sanguinarine, and hence it was deliberately diminish­ed from the poisonous milk in order to bring out its toxic effects on monkeys. These experiments also suggest the importance of giving cysteine to patients during epidemics of argemone oil poison­ing which still continue to occur in India. Further, they may also explain why milk, which could transmit the toxic alkaloids from the plants, is itself portective against the toxicity, as it contains the cysteine factor. The disastrous ocular effects probably occur only when the proportion of the toxin is overwhelming, or when the poison­ing is very prolonged, or the natural cysteine, nor-adrenaline or adrena­line is depleted in the patient by protein deficiency or disease.

  A Carcinogenic Metabolite of Sanguinarine also Transmitted Through Milk Top

The detection techniques deve­loped later in London showed that the milk of goats fed on argemone leaves contained sanguinarine and other alkaloids. This transmission experiment was repeated in London on a group of lactating rabbits that were injected with sanguinarine and subsequently milked. Sanguinarine was detected from several, even 1 ml, samples of such milk. The rabbit milk also showed a green fluoresc­ing metabolite of sanguinarine which was found to be identical with synthetically prepared benz­(c)acridine, the metabolic conversion taking place in the liver (Hakim et al., 1961 b). As benz(c)acridine has the basic molecular structure of a series of the most virulent of ex­perimental carcinogenic hydrocar­bons, according to Prof. Lacassagne from the Radium Institute at Paris, I applied both sanguinarine and benz(c)acridine on the skin of a group of mice, using his method. I also implanted paraffin pellets containing these substances into the bladder of rats, and found after several months that both substances produced, papillomas and carcino­mas in mice and rats. The goat and rabbit experiments clearly proved that lactating animals if fed on sanguinarine-containing plants, could transmit glaucoma-inducing sanguinarine and cancer-inducing benz(c)acridine in their milk.

  Glaucoma and the Hypothalamic Centres Top

Glaucoma is usually considered to be a blinding disease localised in the eye ball in which the normal tension of the intra-ocular fluid is raised by over-secretion or by anatomical, physiological or patho­logical obstruction of its exist channels. A great deal of research has been extended to determine the nature and location of the presumed pathological obstruction, but nothing very definite has as yet evolved out of these studies. On the other hand, there is good evidence that irreversible pathological obstruction only occurs after the disease has progressed very considerably and that the obstruction itself may be the result of a deranged physiology of the eye.

Before we can understand the pathology of glaucoma, we must investigate normal ocular physio­logy and specially study the problem of intra-ocular tension both in health and disease. Some of the following observations and experi­ments indicate that both normal and pathological eye tension are most probably under hypothalamic con­trol from the brain. The intro-ocular tension in the majority of normal human eyes when measured by very precise instruments is between 14 and 17 mm of Hg. and shows slight increase after menstruation and delivery. If the tension is measured both in the morning and in the evening, it is found to show a small - but definite oscillation ranging from 2 to 3 mm Hg., beinq usually higher in the morning. This diurnal variation is independent of activity, sleep, food or light and corresponds to other physiological diurnal rythms such as temperature, sleep, diuresis, etc., which are regu­lated from the brain (Duke-Elder, 1952). When tension in one eye is mechanically raised there is a tendency for it to rise in the other. When fluid is injected into or removed from a dead eye, the pressure changes mechanically and in proportion to the volume intro­duced, but in the living eye, some mechanism actively resists any such change and maintains a normal or nearly normal tension within a considerable range. This also suggests a regulating nervous mechanism (Duke-Elder, 1957). It is now known that the aqueous humour is partly diffused from the blood and that some of its consti­tuents are actively and selectively secreted and that the sympathetic nerve regulates the total blood-flow through the ciliary body and the secretion of protein, vitamin C and glucose but not of urea (Davson, 1956).

In that modern classic on glaucoma-Sir Stewart Duke-Elder's Bowman Lecture, the author em­phasises that the earliest and most significant sign detectable in simple glaucoma, is not an increase in the normal tension but its instability. The diurnal range of oscillation may increase to 30 or 40 mm Hg. and yet its maximum may well be below the accepted normal level. Not only in the early stages, but sometimes during its entire course there may be no rise in tension but only an increase in its range and blindness may result long before raised tension is detected.

At this stage you will realise that the old text-book idea of patholo­gical block in the canal of Schlemm or in the drainage channels, is quite incapable of explaining these normal physiological observations on eye tension, or those when the eye tension changes from the physiological to the pathological pattern. How could any anatomical mechanism cause more blockage in the morning than in the evening or after the menstrual period? When glaucoma has become established, how can a pathological block suddenly disappear during some part of the day so as to produce the widely swinging oscillations in eye tension? When tension has been successfully lowered by a by­pass operation, why do smaller oscillations in eye tension persist ? Then further, how is it that no anatomical block has been demons­trated in early 'simple' glaucoma, either in the canal of Schlemm or any part of the outflow canals in spite of a measurable increase in the resistance to the outflow of aqueous? In. the other type of 'narrow-angle' glaucoma, where the iris angle is narrow, there is no such resistance to outflow and the tension remains normal. Then sud­denly, usually under emotional stress, the iris bulges forward and blocks up the angle alter which the tension shoots up, and an acute, catastrophic and painful attack of glaucoma is precipitated. Francois (1948) emphasises that the point of capital importance is that the closure of the angle precedes the elevation of tension, and that the tension ap­pears only for the period whilst tine angle is closed. Francois also sug­gests that the hypertension is secondary, and the disease is pro­bably situated at the diencephalon (Glaucoma, 1957). The anatomical narrowness of the angle, which may be a predisposing cause, cannot be the basic or the precipi­tating cause of the disease, as it is unknown in the young and. only found in adult eyes affected with glaucoma. The precipitating cause of both types of glaucoma is trig­gered by hormonal, emotional or other disturbances and operates from outside the eye.

It is known that electrical stimu­lation of the cervical sympathetic nerve lowers the eye tension and the chemical blockage of either its ciliary or stellate ganglion or systemic sympathetiocolytic drugs diminish the diurnal variations of eye tension in the normal, glauco­matous and successfully operated eyes. It is also known that visual disabilities, field defects and cup­ping of the discs are not necessarily produced by or related to the degree of eye tension, for some eyes can withstand very high tension for prolonged periods with­out any of the above changes and others rapidly and progressively succumb to such changes in spite of continuous normal tension.

These anomalies in the orthodox mechanical obstructive theory of glaucoma and observations on the influence of the autonomic nervous system on eye tension, paved the way for eminent ophthalmologists like Lagrange, Hamburger, Thiel, Dieter, Duke-Elder, Hartmann, Fran­cois, Radovici, and others to suspect an, extra-ocular neurogenic basis for glaucoma, which Magitot localised to the diencephelon. The glaucomatous eye is not an isolated sick organ in a healthy individual but, as correctly described by Lagrange, a sick eye in a sick body.

  Experiments on the Hypothalamic Centres with Sanguinarine Top

Direct experimental evidence demonstrating that eye tension is regulated from the hypothalamus came from the experiments of von Salmann and Lowenstein in America [Figure - 3] and Gloster and Greaves in England. They placed electrodes into specific areas of the hypothalamus of anaesthetized cats and found that when these areas were stimulated by an electric cur­rent, there was a rise or fall of eye tension independent of the syste­matic blood pressure.

Since our glaucoma patients (luckily) do not have an electrode fixed in their thalamus and since sanguinarine was already known to experimentally raise eye tension, I considered the possibility of the eye tension raising action of this alkaloid as being mediated by chemical stimulation at these hypo­thalamic centres. An opportunity to investigate this possibility came by working in Dr. Feldberg's depart­ment at the National Institute for Medical Research and under his quidance. Feldberq and Sherwood (1953) have devised an ingenious technique by which a metal can­nula is permanently screwed into the skull of cats [Figure - 4]. Repeated injection of drugs can subsequently be made directly into one of the lateral ventricles of the brain even in conscious animals. The very first injection of sanguinarine, in 1957, produced an acute rise of eye tension and was reported to the Physiological Society at its Oxford Meeting.

This interesting observation led to a series of experiments, first in London and later in Bombay. The very small dose of sanguinarine chloride (0.05-0.2 mg) required to raise eye tension when injected into the brain, suggested that it acted upon some exceedingly sensitive mechanism close to the cerebral ventricle and not by direct action after systemic absorption. Intrave­nous sanguinarine, also raises eye tension, but with fifty times the above dose and this action could also be mediated from the small amounts that reach the brain centres. This was shown by destroy­ing the thalamus by various methods and then injecting sangui­narine by vein. When the thalamus had been destroyed, there was no rise of eye tension.

A series of 200 cats have been cannulated. A few days after recovery, their eye tension was measured with a Schiotz tonometer after instilling a few drops of 0.5% amethocaine in normal saline. My colleague and co-worker, the late Miss Freny Doctor, has measured and recorded over 30,000 eye ten­sion. readings in conscious cats. In some animals these were taken three times daily for weeks and months. In control animals she found slightly higher reading of eye tension in the morning, showing a similarity in the diurnal variation in cats and man. For these experiments, sterile injections were made up to a volume of 0.2 ml in normal saline, at normal pH and injected at 35° C. through the rubber bung on the outer end of the can­nula directly into one lateral ven­tricle. Injections of control substan­ces like normal saline, glucose, urea, calcium chloride, Merlis's solution, etc., produced an insignifi­cant or no change in eye tension. Sanguinarine chloride and other ac­tive alkaloids were injected in dos­es of 0.05 to 0.2 mg, the eye tension being recorded before the injection, and at intervals of 15 minutes for one or two hours after the injection. Some of the animals showed mark­ed excitement and wild movements during the first few minutes after the injection. During the next 15 to 60 minutes no symptoms were observed in the cats, this being probably the latent period during which the alkaloid mixed with the cerebrospinal fluid in the lateral ventricle, reached the third ventricle and then seeped into the brain tissue. In most of the experiments with sanguinarine there was an increase in the eye tension, averaging between 5 to 15 mm Hg., with a maximum record of 51 mm Hg., the peak being between 60 and 90 minutes after the injection and the return to basic level after 1 to 2 hours. During the period of raised tension many of the cats showed symptoms suggesting thalamic re­actions like crouching, lowering the head, licking, mewing, salivating, retching, defecating, erecting the spinal hairs and changes in tem­perature. The cats did not tolerate larger doses of sanguinarine and many animals died within 24 to 48 hours after such doses. Although these readings based on the Schidtz tonometer were not considered as absolute values because of the variations in the size and rigidity of the animal eye, they were im­portant in showing the change in the tension when repeatedly meas­ured on the same eye. Several experiments were also performed on cats under central and rabbits under local anaesthesia with a modified Davson-Purvis (1950) mirror-image manometer and the Schihtz readings confirmed and calibrated.

When injections of sanguinarine were repeated 2 or 3 times weekly; using a very small dose, because of their toxicity, some of the cats showed a rise in the basic level of tension which could be sustained for a few weeks only. By that time the general condition of the animals deteriorated rapidly, weight fell due to refusal of food and water and either the injections had to be stopped or the cat died suddenly. It was interesting to observe [Figure - 5] that if sanguinarine had already elevated the basic tension, further injections could produce only a small additional rise. This suggest­ed the operation of some intrinsic mechanism preventing an unlimited rise of eye tension, and added further confirmation to its hypotha­lamic control. Similar experiments were performed on rabbits and monkeys. Sanguinarine produced these acute rises of eye tension even after the animals were injected with decamethonium to rule out eleva­tion of tension by contraction of the Mueller's muscle.

From an experimental point of view, it is unfortunate that when sanguinarine was repeatedly in­jected into the brain for a few weeks, the cats became lethargic, disinclined to eat or drink, and died suddenly. Shevalev, working in Russia on the effects of repeated systemic injections of argemone oil in cats, came across similar difficulties. I have tried single sterile injections of argemone oil in­to the lateral ventricle and found, as in my Oxford experiments, that the oil was very much more toxic than could be accounted for by its sanguinarine contents. Argemone seed-oil 0.01 ml, even when diluted ten times with pure arachis oil, often killed the cats within hours or days. Sanguinarine, either as base or chloride, was incorporated into paraffin tablets and operatively in­troduced into one lateral ventricle to act as a minute steady source of sanguinarine, but this technique proved inert. At present the alkaloid is incorporated into chole­sterol tablets and placed in the brain of Loris monkeys. This technique seems promising. Per­manent elevation of eye tension has been achieved over several weeks in rhesus monkeys fed on argemone or tumaria seed-oil, or by injections of sanguinarine, or best by feeding a synthetic cake into which was incorporated the casein-fat portion of the milk of goats fed on argemone leaves.

  Biochemical Mechanism at the Hypothalamus Top

After injecting sanguinarine or codeine into the brain of cats they sometimes showed great excitement. Reserpine (serpasil) was therefore injected systemically four hours before the brain injection. This rauwolfia alkaloid produced marked quietening in the cats and a fall of blood pressure. The subsequent in­jection of sanguinarine or codeine into the brain produced far greater rise of eye tension than when reserpine had not been given. This indicated that, as with electrical stimulation, chemicals injected in­side the brain could produce raised eye tension even when the blood pressure was lowered. Further, Vogt had shown that reserpine markedly reduces the nor-adrena­line which is normally concentrated in the thalamus and para-ventricular areas of the cat's brain. The area of the distribution of nor-adrenaline is very similar to Sallmann's eye­tension regulating areas. Nor-ad­renaline probably acts as a neuro­chemical buffer in the thalamus and partly antagonises the effects of sanguinarine. When it is diminished by reserpine, the subsequent injec­tion of sanguinarine or codeine is free to act and produce its maximum effect.

Several other active local hor­mones like acetylcholine, mono amine oxidase, and 5-hydroxytrypt­amine are also present and probab­ly produced in the hypothalamus. Drugs like sanguinarine produce their effects by preventing the for­mation, action or destruction of some of these local hormones.

  Sympathetic Nerve Fibres Link Hypothalamic Centres & Eye Ball Top

When sanguinarine is injected into the brain, there is an increase of tension in the eye ball, Obvious­ly there must be some nervous pathway linking the central mecha­nism and the end organ. The possi­bility of raising eye tension by stimulation of the various cranial nerves has been investigated in detail by Sir Stewart's research team in London, and the sympa­thetic seems to be the most likely connecting link. By the application of the cannulation technique, I was able to confirm directly since 1957 that the sympathetic links the tension-controlling brain centres and the eye. In a series of cats, the ventricle was cannulated and the superior cervical nerve or ganglion operatively removed on the right side. Horner's syndrome was produced. After recovery, sanguinarine was injected as usual through the cannula into the ven­tricle. On the right side, where the sympathetic had been removed, there was no rise of eye tension, whilst the tension rose as usual on the intact left side. The detailed discussions regarding the mixed nature of the sympathetic trunk and its relation to eye tension will be published later. Sanguinarine placed as a pool surrounding the superior cervical ganglion, did not block the transmission of tension­lowering effects of electrical stimula­tion of the pre-ganglionic sympathe­tic trunk.

  Direct Action of Sanguinarine on the Retina Top

From the beginning of the experi­mental era, von Graefe himself observed the excavation of the optic disc without raised tension. This view, which subordinated ten­sion, the clinical mainstay of glaucoma, has had the support of Schnabel and Duke-Elder. This suggests that the retinal changes may result from some degenerative or direct toxic action, independently of the tension. Tissue-culture ex­periments I carried out in the laboratory of Sir Edward and Lady Mellanby in 1953 suggested that sanguinarine had a toxic action on the retina apart from and independ­ently of its tension-raising action. Rat embryos were aseptically re­moved and their eyes dissected out. One eye from each embryo was grown in a normal tissue­-culture medium and the other in the medium containing various con­centrations of sanguinarine or argemone oil. In another experi­ment the isolated retinae from embryonic rat eyes were cultured similarly in order to observe the effects of the drug on the retina isolated from other structures. Sanguinarine was also injected in­to the yolk of fertile eggs and the eyes of the chicks examined after hatching. These tissues were fixed and examined microscopically, and the results suggested that sangu­inarine or argemone oil had some direct retinal toxicity. As this was only a pilot experiment, it would repay repetition on a larger scale.

  The Age Factor in Sanguinarine Toxicity Top

A very valuable clue was obtain­ed from another set of experiments regarding the influence of age upon the retinal toxicity of san­guinarine. A group of 30 young rats were fed either on a control diet or one containing sanguinarine or argemone oil for 225 days. The microscopic examination of their eyes showed no retinal toxic effects. Lady Mellanby suggested the re­petition of this prolonged experi­ment using old rats which she supplied from the Nutrition Labora­tory. These old animals were treated like the previous group for 250 days. The subsequent micro­scopic examination of their eyes showed remarkable toxic changes ranging from peripheral, central, segmental to complete degenera­tion of the retina and along the optic nerve. Since these toxic effects were found only in the poisoned animals and only when these were old, it seemed that some biochemical mechanism was pre­venting toxicity in the young rats. Natural protective substances could be the sex hormones, plasma pro­teins, or locally produced tissue hormones like nor- adrenaline, ad­renaline, acetylcholine, irin or kinin and may explain the age incidence for retinal changes in human glaucoma. Further, there may be some co-relation between the de­generaton along the optic nerve known to occur in human glaucoma as far up as the chiasma, and the degeneration of the optic nerve I was able_, to produce in old rats fed with argemone oil or sanguinarine for long periods. Tension within the eye ball cannot possibly pro­duce changes along the optic nerve, which are usually considered as ischaemic in origin. They could possibly be toxic.

  Poppy-seeds & Poppies in the Aetiology of Glaucoma Top

My co-workers found sanguinar­ine in a poppy-seed cake purchased in London. Fortunately the alkaloid although present in some poppy seeds is not found in all. Both poppy and argemone seeds are known to adhere to cereals tc the extent of 10 to 16%. Poppy seeds are fed to poultry as mixed grain and experimental transmis­sion of sanguinarine to the whites of eggs has been demonstrated.

European Jews have a very high incidence of glaucoma and, as a people, consume large amounts of poppy seed and its oil. In Palestine, the seeds and oil are consumed by both Jews and Arabs, and the in­cidence of blindness from glaucoma is 26.3% among the Jews and 21 among the Arabs; but the incid­ence of blindness from all causes is eight times more among the Arabs (Sorsby, 1950). Among these two communities, therefore, although culture, hygiene or treatment diminishes total blindness, these factors have no effect on the in­cidence of glaucoma.

The incidence of glaucoma in European countries, where statis­tics are available, is definitely high in Eastern Europe and highest in Turkistan. Poppy-fumaria species are also far more numerous and prolific in these areas and their populations consume larger amounts of poppy seeds.

The highest recorded incidence of glaucoma is for the Faroe Islands in the North Atlantic. Here the predominant flora is Papaver naudicale L. and various species of Corydalis. Moreover, these plants, rich in sanguinarine, cover vast ice-bound and mountainous areas all over the globe and are often the predominant available fodder for milk and flesh producing animals. Papaver naudicale L, is known to be grazed upon by sheep in Australia where it is recognised to be toxic.

These clinical observations lend considerable support to a toxic basis for glaucoma, particularly re­lated to the poppy-fumaria al­kaloids.

  Opium Addicts & Glaucoma Top

The eye tension of a group of opium habitues in Formosa was re­corded by Konda in 1937, who found it to be normal or slightly raised. There was a wide range in the tension of different patients but, more significantly, it showed ir­regular and marked variations when measured in the same patient from day to day. The latter is exactly what Duke-Elder has des­cribed as the earliest detectable change in glaucoma. I have also studied eye tension in a group of opium addicts and found a very wide range in its diurnal oscilla­tion, and these findings will be published later on. It is significant that, in both groups of subjects absorbing some of the 25 iso­quinoline alkaloids present in opium, instrumentally detectable glaucoma had set in. I would appreciate your co-operation in sending me figures of diurnal variation in eye tension in your patients who may be habitues of opium, morphine, codeine or papaverine.

  The Liberation of Histamine by Poppy Alkaloids in the Aetiology of Glaucoma Top

For over thirty-four years Duke­Elder (1928, 1940) has suspected the action of a histamine-like endogen ous toxin in glaucoma which Frie­denwald (1930) claimed to have found in the aqueous of patients with acute glaucoma. Kirwan (1936) and Chopra (1937) also detected a histamine-like substance in the aqueous of patients suffering from epidemic dropsy glaucoma, but its identity is questionable in the light of modern test methods (Davson, 1956). But what is very significant is that several poppy-fumaria alkaloids like morphine, codeine, papaverine, the baine and apomorphine, when injected into animals, release hista­mine (Feldberg et al., 1951), and that this amine experimentally changes the albumine-globulin ratio in the aqueous. Pathological changes in the tissues and eyes found in human epidemic dropsy glaucoma and those in a few ex­perimental animals, resemble ' some of the toxic effects of histamine. When I injected 0.1-0.2 mg histamine into the brain of cats and rabbits, a rapid but small rise in their eye tension was found.

von Euler (1956) found histamine in the sympathetic nerves of the ox and a definite correlationship between this amine and nor-adren­aline in various nerves. Histamine may be the intermediary in the action of poppy alkaloids and nor­adrenaline in the hypothalamus.

Again, oedema is a sign of argemone oil poisoning but it can also be produced experimentally by apocodeine (Dixon, 1904). These opium alkaloids, probably by releasing tissue histamine, produce central or local effects which may have an important bearing in the aetiology of both glaucoma and oedema. This clinical and experimental comparison supports the toxic theory of glaucoma and widens its possible sources.

  A New Concept of Glaucoma Top

Let me try and present a new concept of glaucoma. It is but a hypothesis, but as you keep it in mind. you will observe how the various experiments I have done or quoted fit into the picture. Glaucoma is a disease probably affecting nerve centres in the brain which regulate eye tension, and often leading to blindness only after many years, during which it is usually insidious and symptomless. The eye ball is the peripheral endorgan and shows secondary damage years after its nervous tension regulating mechanism is diseased. The diffused groups of nerve cells in the hypothalamus which are intimately associated with other thalamic centres such as those regulating temperature, blood pressure, etc., are constantly influ­enced by the conscious brain and respond to emotions of various kinds.

The association of glaucoma with auditory nerve disease and ocular hypotension with Parkinsonism (Brand, 1957) suggests central nervous disturbances affecting the tension, or auditory, or tremor con­trolling centres. The cause of the affection of the nerve centres in the brain could be ingested toxins like sanguinarine or a host of similar alkaloids. If these are ingested insidiously and even occasionally through milk, meat, eggs, poppy seeds or drugs, the process would be intermittent and prolonged over years as is found in non-tropical glaucoma. If the poisoning is massive as when argemone oil contamintates cooking oils, an acute and relatively rapid effect is seen as in tropical epidemic glaucoma.

Coming to the eye ball, we are faced with the problem of the mechanism of normal and raised tension. The volume of aqueous could be regulated by nervous control of the secretory apparatus and the discovery of special nerve endings in the ciliary body, choroid and trabeculi lend support to the concept of a delicately balanced system which regulates blood flow into the eye somewhat like the receptors in the carotid sinus. The nervous arc may be centrally relayed from the hypothalamus or have lower relay pathways, pro­bably in the ganglia of the sympa­thetic trunk. von Graefe, Becker and others have accepted the possibility of increased inflow of aqueous into the restricted capa­city of the eye-ball. However, most authors attribute the raised tension to diminished aqueous outflow and Duke-Elder in his Bowman lecture illustrates its vaso-motor mechanism with great lucidity. The eye tension could also be regulated by the ionic or osmotic effects of some of the substances which are known to be actively secreted under experiment­al sympathetic stimulation. Aceta­zolamide (diamox) reduces eye tension probably by altering the osmotic relationship between plasma and aqueous and not by inhibiting carbonic anhydrase, as is usually believed (Langham, 1957).

My pharmacological experience under Professor Burn and the reminder of the classical experi­ments of Sir Henry Dale, Loewi and Cannon, makes me anticipate a neuro-hormonal mechanism within the eye which liberates active hormones under both local and hypothalamic nervous control, and I am conducting experiments on these lines. These hormones pro­bably produce the known vascular effects. The very fact that von Euler (1954) found considerable amounts of nor-adrenaline and some ad­renaline in the ciliary body, choroid, iris and aqueous of animals and none in the lens, vitreous or retina, suggests that these hormones are concerned with the secretory activity of the eye. These hormones are liberated on sympathetic stimula­tion. Irin is known to be present in the iris and an acetylcholine-like substance was found by Luco and others to be liberated into the aqueous following parasympathetic stimulation. The active secretion of ascorbic acid into the aqueous and its concentration far above that in the plasma would prevent the too rapid destruction of nor­adrenaline and adrenaline and act as an oxygen carrier to the lens and cornea.

From the point of view of neuro­secretion, the eye-ball can be view­ed as a combined secretory and sensory organ showing embryolo­gical and phylogenetic similarities to the vestigial pineal eye, which retains its secretory but has lost its sensory light receptive function except in the rare New Zealand lizard, Sphenodon punctata, and a few other species.

The mechanism of permanently elevated eye tension and the patho­logical changes in the eye has been suggested by Duke-Elder (1957) and has analogies with oscillating systemic blood pressure which preceeds permanent hypertension. We have much to learn in this un­known field.

  Possibility of Endogenous Toxins in the Aetiology of glaucoma Top

Another very important but hitherto unexplored possibility is the toxic effect on the brain centres by endogenous poisons formed in the body of the patient by inborn or induced errors of metabolism, and valuable clues in its search may be found from the biosynthesis or metabolism of sanguinarine. Sir Robert Robinson and Manske sug­gest that poppy-fumaria plants build up the amino-acid tyrosine, change it by steps to nor-laud anosine and eventually to numerous alkaloids including sanguinarine. The animal body used the same amino-acid to synthetize thyroxine and melanin and the two animal alkaloids nor-adrenaline and adrenaline. Adrenaline and sangui­narine, built up from the same precursor by animal and plant, are active biological antagonists in man, sanguinarine producing many of its effects by substrate competi­tion with natural local hormones. In the animal body, sanguinarine is metabolised to the carcinogenic benz(c)acridine, both substances are closely related to phenanthrine and phenanthridine and to a num­ber of active substances like cholesterol, vitamin D, sex hormones and experimental carcinogens. It is possible that some natural or induced error in amino-acid meta­bolism produce a glaucoma-genetic toxin.

  The Legacy of Glaucoma Top

We have come a long way from the days of the Hippocratic school of physicians who saw eyes "green like the sea" and called them 'glaucous'. The torch of knowledge was handed down the ages from Greece to Arabia and Iran. But un­fortunately this epoch was dominat­ed by a hypothetical philosophy of pathology consisting of the 'elements' and 'humours', and the term 'aqueous humour' is a modern reminiscent of this period. After this came the Western renaissance of instrumental ophthalmology, in which the theory of the causation of glaucoma swung away from that of a generalised derangement of the body 'humours' to the localised obstruction of the 'aqueous humour'.

In the pre-instrumental centuries, the symptoms of eye pain and diminished vision and the signs of hardness and opacity of the eye were discovered. All of us now know that these signs and symptoms are usually the terminal events in the course of this insidious disease. With the help of modern instru­ments we can now measure the degree and changes of hardness, examine the depths of the anterior chamber, see and chart the pro­gressive destruction of the retina, medically control or surgically re­lieve the increased pressure. But most of us forget that both raised tension and retinal changes are absent for many years during the developing stages of glaucoma; or so insidious that, in eight hundred thousand persons in the United States of America alone and there must be millions in the whole world-glaucoma has already set in without either patient or doctor being even aware of the disease. Most of us break the very first rule for the early detection of glaucoma by taking a solitary 'measurement of the patient's eye tension, and that too at an evening clinic-just the time when the tension is minimum or absent ! When for the convenience of diagnosis, treatment or prognosis, we divide primary glaucoma into the insidious simple "open angle" type and the catastrophic "narrow" angle type, we are observing two totally differ­ent phenomena in the eye, but behind both may be a common derangement of the nervous ten­sion-regulating mechanism which operates remotely from the brain and is affected by emotion or dis­ease.

The dynamics within the eye ball cannot chart the prognosis of your patients, for even when you operate and succeed in relieving one symptom which is the tension, their vision often continues to de­generate. Even in advanced coun­tries like the United Kingdom, where early detection and adequate treat­ment are available, nearly 60% of cases proceed to blindness. So once again we must return, with the humility that comes from knowledge, to the theory of the derangement of the generalised functioning of the nervous system for a better understanding of the problem of glaucoma. We must not forget that, in spite of the enormous collection of observations and experiments in hospitals and research laboratories throughout the world, we know next to nothing about the cause of glaucoma, very little about the mechanism of rais­ed tension, and can only alleviate and not radically cure the disease.

The story of glaucoma has not ended. Many chapters have yet to be written. A few years ago noth­ing was known about the cause of glaucoma. Now at least we know about argemone 'oil glaucoma and experimental glaucoma with san­guinarine. We have also discover­ed that sanguinarine poisoning is very much more widespread than we had ever thought possible and that it can occur from drugs, milk, eggs and meat. Other plant alkaloids similar to sanguinarine can also be responsible for toxic glaucoma. On the other hand, we have found natural protective substances that can prevent their toxicity. In the experimental in­vestigation of sanguinarine, we have found that it can produce raised eye tension for prolonged periods when injected or fed by certain techniques and that extreme­ly small doses can produce acute rise of eye tension by affecting the nerve centres in the hypothala­mus. We have not yet succeeded in producing a permanently elevat­ed level of eye tension by this means.

The eradication of glaucoma-the second largest cause of blindness in the world-requires your active and intelligent help and co-opera­tion. An open mind, the patience and alertness to inquire into and investigate the presence of toxicity in your patients, the keenness to detect the disease in its early stages, the skill in treating them and above all, the sympathetic understanding of the patient's nerv­ous background which is at the root of the disease, will all be re­quired. Some amongst you could contribute even more by experi­mental research. But whatever be your contribution, let it brighten some cloud in the story of glaucoma and let it give hope and eventual assurance of the joy of seeing.[54]

  References Top

Brand, I. (1957) Ophthalmologica 133, 53  Back to cited text no. 1
Cavka, V. (1956) Arch. d'Opht. 16, 507  Back to cited text no. 2
Chopra, H. & De, N. (1937) Ind. J. med. Res. 25, 101.  Back to cited text no. 3
Davson, H. (1956) Physiology of the Ocular &, Cclcbrospinal Fluids, Churchill, London. IDavson, H. & Purvis, C. (1950) Brit. J. Ophthal. 34, 351.  Back to cited text no. 4
Dieter, (1928) A. f. Aug. 49, 678.  Back to cited text no. 5
Dixon, NV. (1904) J. Physiol. 30, 97.  Back to cited text no. 6
Dobbie, G. & Langham, M (1961) Brit. J. Ophthal. 45, 81.  Back to cited text no. 7
Duke-Elder, S. (2928) . The Aetiology of Glaucoma. Brit. med. J. August II th.  Back to cited text no. 8
Duke-Elder, S. (1940) Text-Book of Ophthalmology, 3, 3280-3429, Henry Kimpton, London.  Back to cited text no. 9
Duke-Elder, S. (1954) Text-Book of Ophthalmology, 6, 6852-6855, Henry Kimpton, London.  Back to cited text no. 10
Duke-Elder, S. (1952) The Phasic Variations in the Ocular Tension in Primary Glaucoma. Am. J. Ophthal. 35. 1.  Back to cited text no. 11
Duke-Elder, S, (1957) The Boman Lecture-The Aetiology of Simple Glau­coma, Trans. Ophthal. Soc. 1'. K. 77, 205.  Back to cited text no. 12
Duller, H., von Euler, U, & Pernow, B. (1954) Acta Physiol. Scand. 31, 113.  Back to cited text no. 13
von Euler, U. (1956) Noradrenaline, p. 139, 164, Charles Thomas, Springfield. Fedde, F. (1909) Das Pflanzenrech. ed. Engler, H. 40, Leipzig.  Back to cited text no. 14
Feldberg, W. & Paton, W. (1951) J. Physiol. 114, 490.  Back to cited text no. 15
Feldberg, W. & Sherwood, S. (1953) J. Physiol. 120, 3 P.  Back to cited text no. 16
Francois, j. (1948) Annales d'Oculistique 181, 399.  Back to cited text no. 17
Fricdenwald, (1930) Amer, J. Ophthal. 3, 56o, 574.  Back to cited text no. 18
Gloster, J. & Greaves, D. (1957) Brit. J. Ophthal. 41, 513.  Back to cited text no. 19
von Graefe, (1857) Archiv fur Ophthal­mologic 3, 456.  Back to cited text no. 20
Hakim, S. (1953) D, Phil. Thesis, University- of Oxford.  Back to cited text no. 21
Hakim, S. (1954) Argemone Oil, San­guinarine, & Epidemic-Dropsy Glaucoma. Brit. J. Ophthal. 38, 193.  Back to cited text no. 22
Hakim, S. (1957a) Extraction & Detec­tion of Poppy Alkaloids. J. Physiol. 138, 8 P.  Back to cited text no. 23
Hakim, S. (1057b) Poppy Alkaloids & Glaucoma. J. Physiol. 138, 40 P.  Back to cited text no. 24
Hakim, S. Mijovic, V. & Walker, J. (1961a) Poppy Alkaloids & Glaucoma Nature, 189, 198,  Back to cited text no. 25
Hakim, S. Mijovic, V. & ``Walker, J. (1961b) Transmission of Sanguinarine &, a Metabolic Product in Milk. Nature, 189, 201.  Back to cited text no. 26
Hamburger, (1924) bled. kl, 20, 274.  Back to cited text no. 27
Hamburger, (1925) D. med, W. 51, 186,  Back to cited text no. 28
Hartmann, E. (1952) Annales d'Oculisti­que. 185, 438.  Back to cited text no. 29
Hutchinson, J. (1921) Kew Bull. No. 3. P. 97.  Back to cited text no. 30
Indraji, T. J. (1910) Vanaspati Shastre (Gujerati) P. 23-27. Bombay.  Back to cited text no. 31
Jadavji, A. (1950) Dravya-Guna-Gnyan (Hindi) p. 86-87. Nirnaya Sagar, Bombay.  Back to cited text no. 32
Kanda, K, & So, K. (1933) Brit. J. Ophthal. 17, 354.  Back to cited text no. 33
Kirwan, E. (1936) Brit. J. Ophthal. 20, 321.  Back to cited text no. 34
Lacassagne. A. et. al., (1956) Advances in Cancer Research 4, 315.  Back to cited text no. 35
Lagrange, F. (1922) Du Glocome et de l'Hypotonie, Paris.  Back to cited text no. 36
Langham, M. &. Lee, P. (1957) Brit. J. Ophthal. 41, 65.  Back to cited text no. 37
Leib, W. & Scherf, H. (1956) Klin. Mbl. Augenheilk. 128, 686.  Back to cited text no. 38
Luco, J. & Lissak, K, (1938) Amer. J. Physiol. 124, 271.  Back to cited text no. 39
Majitot, A. (1949) Bull. Socs. d'Ophtal. 27, 1193,  Back to cited text no. 40
Manske, R, (1954) The Alkaloids. vol. 4. Academic Press Inc., New York.  Back to cited text no. 41
Radovici, (1955) Ann. ocul., 188, 881.  Back to cited text no. 42
Robinson, R. (1948) J. R. Soc. Arts. 96, 806. (and personal guidance).  Back to cited text no. 43
Robinson, R. (1955) The Structural Relations of Natural Products p. 89. Clarendon Press, Oxford.  Back to cited text no. 44
von Sallmann, L. & Lowenstein, O. (1955) Amer. J. Ophthal. 39, (suppl) II.  Back to cited text no. 45
Shevalev, A. (1957) Bengal Glaucoma. (Russian). L. Dancheva, Odessa.  Back to cited text no. 46
Sorsbv, A. (1950) Incidence & Causes of Blindness. Brit. J. Ophthal. (sup). xiv.  Back to cited text no. 47
Thiel, R. (1926) Klin. Mbl. Augenheilk. 77, 753.  Back to cited text no. 48
Thief, R. (1955) Auge and Zwischenhirn. Bucheri des Augenarztes 23, 166. Beihfte der Klin. Mbl. Augenheilk.  Back to cited text no. 49
Vogt, M. (1957) Brit. med. Bull. 13, 166  Back to cited text no. 50
Glaucoma, A. Symposium on. Ed. Duke-Elder, S. (1955), 2nd ed. (1957) Black well, Oxford.  Back to cited text no. 51
Glaucoma, Trans. 1st Conference on. Ed. Newell, F. (1956) J. Macy, New York.  Back to cited text no. 52
Glaucoma, Symposium on. Ed. Clark, W. (1959) Mosby, St. Louis.  Back to cited text no. 53
Report. National Society for the Prevention of Blindness U.S.A. (1950).  Back to cited text no. 54


  [Figure - 1], [Figure - 2], [Figure - 3], [Figure - 4], [Figure - 5]

  [Table - 1], [Table - 2]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
A West Indies Po...
Epidemic-dropsy ...
Sanguinarine & O...
Transmission of ...
Protective Actio...
A Carcinogenic M...
Glaucoma and the...
Experiments on t...
Biochemical Mech...
Sympathetic Nerv...
Direct Action of...
The Age Factor i...
Poppy-seeds & Po...
Opium Addicts & ...
The Liberation o...
A New Concept of...
Possibility of E...
The Legacy of Gl...
Article Figures
Article Tables

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal